U.S. markets open in 2 hours 29 minutes
  • S&P Futures

    4,042.00
    -16.75 (-0.41%)
     
  • Dow Futures

    33,295.00
    -213.00 (-0.64%)
     
  • Nasdaq Futures

    12,958.75
    -39.75 (-0.31%)
     
  • Russell 2000 Futures

    2,119.10
    -12.40 (-0.58%)
     
  • Crude Oil

    64.16
    -1.92 (-2.91%)
     
  • Gold

    1,813.00
    -9.80 (-0.54%)
     
  • Silver

    26.92
    -0.33 (-1.21%)
     
  • EUR/USD

    1.2073
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.6950
    0.0000 (0.00%)
     
  • Vix

    27.61
    +5.77 (+26.42%)
     
  • GBP/USD

    1.4022
    -0.0035 (-0.25%)
     
  • USD/JPY

    109.6370
    -0.0230 (-0.02%)
     
  • BTC-USD

    49,207.86
    -6,862.96 (-12.24%)
     
  • CMC Crypto 200

    1,311.28
    -252.55 (-16.15%)
     
  • FTSE 100

    6,857.23
    -147.40 (-2.10%)
     
  • Nikkei 225

    27,448.01
    -699.50 (-2.49%)
     

AKER: Final Settlement Hearing Rescheduled to December 20, 2019

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the hearing to determine whether to approve a proposed class action settlement that would benefit purchasers of Akers Biosciences, Inc. (“Akers”) common stock (AKER), originally scheduled for November 8, 2019 at 2:30 p.m., has been rescheduled. The hearing will be held on December 20, 2019, at 11:00 a.m. before the Honorable Esther Salas, United States District Judge of the District of New Jersey, Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Courtroom MLK 5A, Newark, New Jersey 07102.

If you have any questions about the Settlement, you may call or write to Lead Counsel or to the Claims Administrator:

THE ROSEN LAW FIRM, P.A.
Laurence M. Rosen, Esq.
609 W. South Orange Avenue, Suite 2P
South Orange, NJ 07079
Tel: (973) 313-1887
Fax: (973) 833-0399

Akers Biosciences, Inc. Securities Litigation
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
Tel.: 866-274-4004
Fax: 610-565-7985
info@strategicclaims.net